Mahoney Michael F — SEC insider filings
SEC reporting owner CIK 1533022. 66 insider filings on record with FilingPulse; latest filed 2026-11-06.
Transaction summary — filings shown
Covers the 50 most recent of 66 filings on record, filed 2022-02-23 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 225,421 shares, $11,502,701 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 19 legs across 14 filings — 1,985,937 shares, $144,621,218 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 162.
- Largest priced transaction: sale of 164,442 shares @ $100.01 ($16,445,072) in BOSTON SCIENTIFIC CORP, filed 2025-04-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BOSTON SCIENTIFIC CORP (BSX) | Chairman, President & CEO, Director | 40 | 1 leg · 186,240 sh · $9,001,408 | 19 legs · 1,985,937 sh · $144,621,218 | 153 |
| CVS HEALTH Corp (CVS) | Director | 8 | 2 legs · 39,181 sh · $2,501,294 | — | 7 |
| BAXTER INTERNATIONAL INC (BAX) | Director | 2 | — | — | 2 |
Insider filings — Mahoney Michael F
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-06 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Gift (G): 149,992 @ $0 · Gift (G): 102,249 @ $0 | EDGAR |
| 2026-08-05 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Purchase (P): 186,240 @ $48.33 · Code (I): 22,119 @ $48.43 | EDGAR |
| 2026-06-01 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Gift (G): 386,755 @ $0 | EDGAR |
| 2026-05-15 | 4 | CVS HEALTH Corp (CVS) | Grant/award (A): 1,737.00 (derivative) @ $97.15 | EDGAR |
| 2026-02-18 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 132,190 @ $0 · Grant/award (A): 132,190 @ $0 · Option exercise (M): 8,832 @ $0 · Tax withholding (F): 132,099 @ $74.73 · Option exercise (M): 16,524 @ $0 · Tax withholding (F): 7,990 @ $74.73 · +5 more | EDGAR |
| 2026-02-17 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 13,704 @ $0 · Tax withholding (F): 6,626 @ $74.12 · Option exercise (M): 13,704 (derivative) @ $0 · Grant/award (A): 55,652 (derivative) @ $0 · Grant/award (A): 131,329 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 49,407 @ $24.55 · Option exercise (M): 46,347 @ $27.09 · Sale (S): 1,200 @ $94.06 · Sale (S): 159,701 @ $93.49 · Option exercise (M): 46,347 (derivative) @ $0 · Option exercise (M): 49,407 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | CVS HEALTH Corp (CVS) | Grant/award (A): 2,021.96 (derivative) @ $76.04 | EDGAR |
| 2025-10-31 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Gift (G): 88,197 @ $0 · Gift (G): 73,996 @ $0 · Gift (G): 149,992 @ $0 | EDGAR |
| 2025-06-03 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 56,212 @ $17.26 · Option exercise (M): 49,407 @ $24.55 · Sale (S): 74,522 @ $104.05 · Sale (S): 89,921 @ $103.39 · Option exercise (M): 56,212 (derivative) @ $0 · Option exercise (M): 49,407 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | CVS HEALTH Corp (CVS) | Grant/award (A): 144 @ $60.47 · Grant/award (A): 2,542.58 (derivative) @ $60.47 | EDGAR |
| 2025-05-05 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 56,212 @ $17.26 · Option exercise (M): 49,407 @ $24.55 · Sale (S): 73,161 @ $102.92 · Sale (S): 91,282 @ $102.13 · Option exercise (M): 56,212 (derivative) @ $0 · Option exercise (M): 49,407 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 56,211 @ $17.26 · Option exercise (M): 49,407 @ $24.55 · Sale (S): 164,442 @ $100.01 · Option exercise (M): 56,211 (derivative) @ $0 · Option exercise (M): 49,407 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | CVS HEALTH Corp (CVS) | Purchase (P): 30,000 @ $66.70 | EDGAR |
| 2025-02-18 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 16,524 @ $0 · Tax withholding (F): 7,990 @ $106.11 · Option exercise (M): 16,265 @ $0 · Tax withholding (F): 7,865 @ $106.11 · Option exercise (M): 18,334 @ $0 · Tax withholding (F): 8,865 @ $106.11 · +5 more | EDGAR |
| 2025-02-14 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 13,704 @ $0 · Tax withholding (F): 6,626 @ $105.77 · Option exercise (M): 13,704 (derivative) @ $0 | EDGAR |
| 2025-02-13 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 130,118 @ $0 · Tax withholding (F): 62,915 @ $105.98 | EDGAR |
| 2025-01-03 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 57,121 @ $0 · Tax withholding (F): 25,656 @ $89.32 · Option exercise (M): 57,121 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Gift (G): 7,800 @ $0 | EDGAR |
| 2024-11-25 | 4 | CVS HEALTH Corp (CVS) | Grant/award (A): 2,200 @ $57.10 | EDGAR |
| 2024-11-07 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 56,211 @ $17.26 · Option exercise (M): 55,676 @ $16.31 · Sale (S): 2,596 @ $85.17 · Sale (S): 160,182 @ $84.74 · Option exercise (M): 56,211 (derivative) @ $0 · Option exercise (M): 55,676 (derivative) @ $0 | EDGAR |
| 2024-10-08 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 56,211 @ $17.26 · Option exercise (M): 55,675 @ $16.31 · Sale (S): 80,692 @ $84.31 · Sale (S): 82,085 @ $84.94 · Option exercise (M): 56,211 (derivative) @ $0 · Option exercise (M): 55,675 (derivative) @ $0 | EDGAR |
| 2024-09-06 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 56,211 @ $17.26 · Option exercise (M): 55,675 @ $16.31 · Sale (S): 162,777 @ $81.17 · Option exercise (M): 56,211 (derivative) @ $0 · Option exercise (M): 55,675 (derivative) @ $0 | EDGAR |
| 2024-09-03 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Gift (G): 114,237 @ $0 · Gift (G): 95,041 @ $0 · Gift (G): 176,245 @ $0 | EDGAR |
| 2024-05-17 | 4 | CVS HEALTH Corp (CVS) | Grant/award (A): 2,184 @ $57.52 | EDGAR |
| 2024-05-02 | 4 | CVS HEALTH Corp (CVS) | Purchase (P): 9,181 @ $54.49 | EDGAR |
| 2024-02-20 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 16,265 @ $0 · Tax withholding (F): 7,214 @ $65.82 · Option exercise (M): 18,333 @ $0 · Tax withholding (F): 8,131 @ $65.82 · Option exercise (M): 16,307 @ $0 · Tax withholding (F): 7,233 @ $65.82 · +3 more | EDGAR |
| 2024-02-16 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 16,523 @ $0 · Tax withholding (F): 7,328 @ $65.95 · Option exercise (M): 16,523 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 54,816 (derivative) @ $0 · Grant/award (A): 144,516 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 146,666 @ $0 · Tax withholding (F): 65,047 @ $0 | EDGAR |
| 2024-01-02 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 95,919 @ $0 · Tax withholding (F): 40,104 @ $57.81 · Option exercise (M): 95,919 (derivative) @ $0 | EDGAR |
| 2023-11-17 | 4 | CVS HEALTH Corp (CVS) | Grant/award (A): 1,817 @ $69.13 | EDGAR |
| 2023-11-07 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 57,681 @ $13.08 · Option exercise (M): 55,675 @ $16.31 · Sale (S): 113,356 @ $52.51 · Option exercise (M): 55,675 (derivative) @ $0 · Option exercise (M): 57,681 (derivative) @ $0 | EDGAR |
| 2023-10-10 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 57,680 @ $13.08 · Option exercise (M): 55,675 @ $16.31 · Sale (S): 113,355 @ $52.09 · Option exercise (M): 55,675 (derivative) @ $0 · Option exercise (M): 57,680 (derivative) @ $0 | EDGAR |
| 2023-09-12 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 57,680 @ $13.08 · Option exercise (M): 55,675 @ $16.31 · Sale (S): 113,355 @ $53.91 · Option exercise (M): 55,675 (derivative) @ $0 · Option exercise (M): 57,680 (derivative) @ $0 | EDGAR |
| 2023-09-01 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Gift (G): 318,218 @ $0 · Gift (G): 141,450 @ $0 · Gift (G): 1,095 @ $0 | EDGAR |
| 2023-05-04 | 4 | BAXTER INTERNATIONAL INC (BAX) | Grant/award (A): 4,573 @ $0 | EDGAR |
| 2023-02-22 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 16,825 @ $0 · Tax withholding (F): 7,462 @ $46.23 · Option exercise (M): 16,825 (derivative) @ $0 | EDGAR |
| 2023-02-21 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 16,264 @ $0 · Tax withholding (F): 7,214 @ $46.48 · Option exercise (M): 18,333 @ $0 · Tax withholding (F): 8,131 @ $46.54 · Option exercise (M): 16,307 @ $0 · Tax withholding (F): 7,233 @ $46.54 · +3 more | EDGAR |
| 2023-02-16 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 18,457 @ $0 · Tax withholding (F): 8,186 @ $47.29 · Option exercise (M): 18,457 (derivative) @ $0 | EDGAR |
| 2023-02-15 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 57,121 (derivative) @ $0 · Grant/award (A): 66,095 (derivative) @ $0 · Grant/award (A): 171,984 (derivative) @ $0 | EDGAR |
| 2023-01-03 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 57,791 @ $0 · Tax withholding (F): 22,576 @ $46.27 · Option exercise (M): 57,791 (derivative) @ $0 | EDGAR |
| 2022-11-08 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 82,567 @ $7.39 · Option exercise (M): 43,260 @ $13.08 · Sale (S): 125,827 @ $41.97 · Option exercise (M): 43,260 (derivative) @ $0 · Option exercise (M): 82,567 (derivative) @ $0 | EDGAR |
| 2022-10-04 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 82,567 @ $7.39 · Option exercise (M): 43,260 @ $13.08 · Sale (S): 125,827 @ $39.34 · Option exercise (M): 43,260 (derivative) @ $0 · Option exercise (M): 82,567 (derivative) @ $0 | EDGAR |
| 2022-09-07 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Gift (G): 365,457 @ $0 · Option exercise (M): 82,567 @ $7.39 · Option exercise (M): 43,261 @ $13.08 · Sale (S): 125,828 @ $40.49 · Option exercise (M): 43,261 (derivative) @ $0 · Option exercise (M): 82,567 (derivative) @ $0 | EDGAR |
| 2022-08-09 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 82,567 @ $7.39 · Option exercise (M): 43,261 @ $13.08 · Sale (S): 125,828 @ $40.97 · Option exercise (M): 43,261 (derivative) @ $0 · Option exercise (M): 82,567 (derivative) @ $0 | EDGAR |
| 2022-05-05 | 4 | BAXTER INTERNATIONAL INC (BAX) | Grant/award (A): 2,706 @ $0 | EDGAR |
| 2022-03-02 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 18,330 @ $0 · Tax withholding (F): 8,130 @ $44.17 · Option exercise (M): 18,330 (derivative) @ $0 | EDGAR |
| 2022-02-24 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 95,919 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 16,825 @ $0 · Tax withholding (F): 7,462 @ $42.55 · Option exercise (M): 16,825 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1533022 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs